Related Experiment Video

Updated: Feb 10, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

12.6K

Nuclear Export Inhibition for Pancreatic Cancer Therapy

Irfana Muqbil1, Asfar S Azmi2, Ramzi M Mohammad3

  • 1Department of Chemistry, University of Detroit Mercy, Detroit, MI 48221, USA. muqbilr@udmercy.edu.

Cancers
|May 9, 2018
PubMed

Insights

Pancreatic cancer lacks effective treatments. Targeting the nuclear exporter XPO1 (exportin 1) shows promise by restoring tumor suppressor proteins, offering a new therapeutic strategy for this deadly cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Pancreatic cancer is a highly lethal disease with limited therapeutic options, especially for metastatic cases.
  • Effective drugs to improve survival in advanced pancreatic cancer are urgently needed.
  • Nuclear protein transport is crucial for regulating tumor suppressor proteins (TSPs).

Purpose of the Study:

  • To review the role of the nuclear exporter XPO1 (exportin 1) in pancreatic cancer.
  • To highlight XPO1 as a potential therapeutic target for pancreatic cancer.
  • To discuss the mechanism of XPO1 inhibition in cancer treatment.

Main Methods:

  • Review of current scientific literature on XPO1, pancreatic cancer, and nuclear transport.
  • Analysis of the role of XPO1 in the dysregulation of tumor suppressor proteins.
  • Examination of small molecule inhibitors targeting XPO1.

Main Results:

  • High expression of XPO1 in pancreatic cancer leads to the export and inactivation of critical TSPs.
  • Inhibiting XPO1 can restore TSP function by retaining them in the nucleus.
  • This mechanism results in the effective killing of pancreatic cancer cells.

Conclusions:

  • XPO1 is a clinically viable and unique drug target in pancreatic cancer.
  • Blocking nuclear export via XPO1 inhibition offers a novel therapeutic strategy.
  • Further research into XPO1 inhibitors may lead to improved outcomes for pancreatic cancer patients.
Keywords:
CRM1Exportin-1Pancreatic CancerPancreatic Ductal AdenocarcinomaPhase ISINESpecific Inhibitors of Nuclear Exportnuclear protein export

More Related Videos

Analysis of mRNA Nuclear Export Kinetics in Mammalian Cells by Microinjection11:32

Analysis of mRNA Nuclear Export Kinetics in Mammalian Cells by Microinjection

Published on: December 4, 2010

15.8K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.9K

Related Concept Videos

Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

5.5K
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
5.0K
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K